hydroxyurea and osalmide

hydroxyurea has been researched along with osalmide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Chen, X; Chen, Z; Hou, C; Lin, Q; Liu, X; Lou, M; Qiu, Y; Shao, J; Song, R; Wang, M; Xu, Z; Yang, C; Zhu, L; Zhu, W1
Shao, J; Tang, Q; Wu, L; Xu, M; Yan, D; Yan, S1

Other Studies

3 other study(ies) available for hydroxyurea and osalmide

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein.
    Biochemical pharmacology, 2016, Mar-01, Volume: 103

    Topics: Animals; Antiviral Agents; Cell Line, Tumor; DNA Replication; DNA, Circular; DNA, Viral; Drug Resistance, Viral; Drug Synergism; Genome, Viral; Hepatitis B virus; Humans; Hydroxyurea; Lamivudine; Liver; Mice; Mutation; Ribonucleoside Diphosphate Reductase; Salicylanilides; Virus Replication

2016
Osalmid, a Novel Identified RRM2 Inhibitor, Enhances Radiosensitivity of Esophageal Cancer.
    International journal of radiation oncology, biology, physics, 2020, 12-01, Volume: 108, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Deoxyribonucleosides; DNA Damage; Esophageal Neoplasms; Female; Gene Knockdown Techniques; Humans; Hydroxyurea; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Phosphorylation; Radiation Tolerance; Radiation-Sensitizing Agents; Ribonucleoside Diphosphate Reductase; Salicylanilides

2020